CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Published:Mar 23, 2019
Last Modified:Nov 21, 2024
EPS:Mar 23, 2019
EPSS Score:0.00439
CVSS Score:8.8
Affected Products
Vendor
Product
Action
Vendor
Pfizer
Product
Symbiq Infusion System
Pfizer
Symbiq Infusion System
Vendor
Pfizer
Product
Symbiq Infusion System Firmware
Pfizer
Symbiq Infusion System Firmware
Exploits
No exploit reference
Common Weakness Enumeration
No CWE recorded yet
Common Attack Pattern Enumeration and Classification (CAPEC)
No CAPEC recorded yet
Common Vulnerability Scoring System
Attack Vector
Network
Adjacent
Local
Physical
Privileges Required
None
Low
High
User Interaction
None
Required
Scope
Unchanged
Changed
Confidentiality
None
Low
High
Integrity
None
Low
High
Availability
None
Low
High
